Elezanumab Granted Orphan Drug, Fast Track Designations for Spinal Cord Injury
Elezanumab is a monoclonal antibody of the human IgG1 isotype that works by binding selectively to repulsive guidance molecule A.
Pain Management
Gabapentin Does Not Lower Pain Scores in Chronic Pelvic Pain
Treatment also linked to more serious adverse events.
FDA Requires Boxed Warning Update for Benzodiazepines
Benzodiazepines are widely used to treat a variety of conditions including anxiety disorders, insomnia and seizures.
FDA Cracks Down on Websites Illegally Selling Opioids
The unapproved and misbranded opioids, which include tramadol and oxycodone, are being sold without a prescription.
Medical Marijuana Tied to Fewer Admissions in Sickle Cell Disease
But no change in opioid use observed for those receiving medical marijuana certification
Qdolo Approved for Pain Management
Qdolo contains tramadol, an opioid agonist and inhibitor of norepinephrine and serotonin reuptake.
FDA: Stimulation Trial Should Be Performed Before Implanting SCS for Pain
The FDA reported that between July 27, 2016 and July 27, 2020, a total of 107,728 medical device reports (MDRs) associated with SCS devices intended for pain were received.
XaraColl Implant Approved for Postop Pain Following Hernia Repair
The approval was based on data from 2 placebo-controlled phase 3 studies that evaluated the efficacy and safety of XaraColl for postoperative pain in 610 adults scheduled for open inguinal hernia surgery.
About Half of Waivered Clinicians Prescribe Buprenorphine for OUD
Percentages much higher for actively prescribing U.S. clinicians with 275 and 100 versus 30 patients
Orphengesic Forte Now Available for Pain Management
The safety of long-term Orphengesic Forte use has not been established.
